Mon panier

BACE-1

BACE-1 Informations sur la molécule

Nom anglaisBeta-secretase 1Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3Alias de la cibleBeta-site amyloid precursor protein cleaving enzyme 1,KIAA1149,Asp 2,ASP2,Aspartyl protease 2,BACE,BACE1,Beta-Secretase 1,Membrane-Associated Aspartic Protease 2,Beta-Site APP-Cleaving Enzyme,Memapsin-2,Transmembrane Aspartic Proteinase Asp2,Beta-Site APP-Cleaving Enzyme 1,APP Beta-Secretase,EC 3.4.23.46,HSPC104,EC 3.4.23,Beta-Site APP Cleaving Enzyme 1,Beta-Site Amyloid Beta A4 Precursor Protein-Cleaving Enzyme,Beta-Secretase 1 Precursor Variant 1,EC:3.4.23.46
Phase de R&D la plus avancéePhase 3 Clinical
Nom anglaisBeta-secretase 1
Alias de la cibleBeta-site amyloid precursor protein cleaving enzyme 1,KIAA1149,Asp 2,ASP2,Aspartyl protease 2,BACE,BACE1,Beta-Secretase 1,Membrane-Associated Aspartic Protease 2,Beta-Site APP-Cleaving Enzyme,Memapsin-2,Transmembrane Aspartic Proteinase Asp2,Beta-Site APP-Cleaving Enzyme 1,APP Beta-Secretase,EC 3.4.23.46,HSPC104,EC 3.4.23,Beta-Site APP Cleaving Enzyme 1,Beta-Site Amyloid Beta A4 Precursor Protein-Cleaving Enzyme,Beta-Secretase 1 Precursor Variant 1,EC:3.4.23.46
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3
Phase de R&D la plus avancéePhase 3 Clinical

BACE-1 Liste de produits

  • Attribut

    Protein (3)

  • Bibliothèque de produits

    En ligne (3)

  • Espèces

    Human (3)

  • Étiquette

    His Tag (1)Fc Tag (1)Tag Free (1)

  • Marqueur

    Unconjugated (3)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
BA1-H5213
Human
HEK293
Human BACE-1 Protein, Tag Free (active enzyme, MALS verified)
Ajouter au panier
BA1-H5220
Human
HEK293
Human BACE-1 Protein, His Tag (active enzyme, MALS verified)
Ajouter au panier
BA1-H5261
Human
HEK293
Human BACE-1 Protein, Fc Tag
Ajouter au panier
Quantité totale3
  • 1

BACE-1Contexte de la molécule

Beta-secretase 1 (BACE1) is also known as beta-site APP cleaving enzyme 1 (beta-site amyloid precursor protein cleaving enzyme 1), memapsin-2 (membrane-associated aspartic protease 2), and aspartyl protease 2 (ASP2), β-Secretase , and is a member of the peptidase A1 protein family, BACE1 is a type I  integral membrane glycoprotein and aspartic protease that is found mainly in the Golgi. BACE1 is an aspartic-acid protease important in the pathogenesis of Alzheimer's disease, and in the formation of myelin sheaths in peripheral nerve cells. The transmembrane protein contains two active site aspartate residues in its extracellular protein domain and may function as a dimer. This protease is responsible for the proteolytic processing of the amyloid precursor protein (APP). Generation of the 40 or 42 amino acid-long amyloid-β peptides that aggregate in the brain of Alzheimer's patients requires two sequential cleavages of the APP. Extracellular cleavage of APP by BACE creates a soluble extracellular fragment and a cell membrane-bound fragment referred to as C99. The elevation of BACE1 levels can be induced by amyloid plaques surrounding neurons at early stages of pathology before neuron death occurs, and may drive a positive-feedback loop in AD.

BACE-1Alias de la molécule

BACE1,ASP2,BACE,FLJ90568,HSPC104,KIAA1149,Memapsin-2,Beta-Secretase,β-secretase

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
LanabecestatAZD-3293; LY-3314814Phase 3 ClinicalAstrazeneca PlcAlzheimer Disease; Hepatic Insufficiency; Renal Insufficiency
Details
ElenbecestatE-2609Phase 3 ClinicalEisai Co LtdAlzheimer Disease
Details
TAK-070TAK-070Phase 1 ClinicalTakeda Pharmaceutical Co LtdAlzheimer Disease
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques